New Approach Mimicking The Body's Natural Defenses Could Help Treat A Therapy-Resistant Breast Cancer

Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells - receptors for the hormones estrogen or progesterone, or a co-receptor, called HER2, that binds to many growth factors. But about one in every six breast tumors has none of these receptors. Such cancers, called triple-negative, are particularly aggressive and notoriously difficult to treat...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Breast Cancer Source Type: news